New markers could improve heart attack prognosis

NCT ID NCT03070496

Completed Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study followed 281 people who had a severe type of heart attack called STEMI. Researchers collected blood samples, ECGs, MRIs, and quality-of-life questionnaires to find new biological and imaging markers that could help predict outcomes like heart failure. The goal is to improve how doctors assess recovery and tailor treatment after a heart attack.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to predict recovery and complications after a heart attack, improving patient care.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change patient outcomes, and findings may need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STEMI - ST ELEVATION MYOCARDIAL INFARCTION

Contacts and locations

Locations

CHU Strasbourg

Strasbourg, 67091, France
CHU de Tours

Tours, France
Hôpital Cardiovasculaire Louis Pradel

Bron, 69677, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.